Page last updated: 2024-10-29

staurosporine aglycone and Bicuspid Aortic Valve Disease

staurosporine aglycone has been researched along with Bicuspid Aortic Valve Disease in 1 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Bicuspid Aortic Valve Disease: Congenital heart valve defects where the AORTIC VALVE has two instead of normal three cusps. It is often associated with AORTIC REGURGITATION and AORTIC INSUFFICIENCY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Yao, Q1
The, E1
Ao, L1
Zhai, Y1
Osterholt, MK1
Fullerton, DA1
Meng, X1

Other Studies

1 other study available for staurosporine aglycone and Bicuspid Aortic Valve Disease

ArticleYear
TLR4 Stimulation Promotes Human AVIC Fibrogenic Activity through Upregulation of Neurotrophin 3 Production.
    International journal of molecular sciences, 2020, Feb-14, Volume: 21, Issue:4

    Topics: Aortic Valve; Bicuspid Aortic Valve Disease; Carbazoles; Cell Proliferation; Cells, Cultured; Collag

2020